140
Participants
Start Date
November 30, 1995
Primary Completion Date
August 31, 2003
Study Completion Date
April 30, 2006
Aldesleukin (IL-2)
Infusion for a total of 96 hours on days 1-4
Recombinant Interferon Alfa (IFN-A)
"IFN-A Therapy Groups:~Schedule A: IV IFN-A induction 5 times a week for 4 weeks followed by subcutaneous IFN-A maintenance 3 times a week for 48 weeks.~Schedule B: Subcutaneous IFN-A 3 times a week for 52 weeks~Adjuvant Biochemotherapy Group: IFN-A is given subcutaneously on days 1-5"
Cisplatin
IV Days 1-4
Dacarbazine
IVPB on day 1
Vinblastine
IVPB on days 1-4
Adjuvant Therapy
Patients receiving adjuvant radiotherapy will start adjuvant systemic therapy within 8 weeks from lymphadenectomy and a week after completion of and recovery from radiotherapy.
University of Texas - MD Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER